نتایج جستجو برای: secondary progressive multiple sclerosis

تعداد نتایج: 1161733  

Journal: :Disability and rehabilitation 2017
Emer O'Loughlin Susan Hourihan Jeremy Chataway E Diane Playford Afsane Riazi

PURPOSE The majority of people with multiple sclerosis (pwMS) initially present with discreet periods of relapses followed by partial remission of symptoms (RRMS). Over time, most pwMS transition to secondary progressive MS (SPMS), characterized by a gradual accumulation of disability. This study aimed to explore the experiences, coping and needs associated with transitioning from RRMS to SPMS....

Journal: :Neurology 2003
D S Goodin B G Arnason P K Coyle E M Frohman D W Paty

Mitoxantrone is the first drug approved for the treatment of secondary progressive multiple sclerosis (SPMS) in the United States. This assessment considers use of mitoxantrone in the treatment of MS. Mitoxantrone probably reduces the clinical attack rate and reduces attack-related MRI outcomes in patients with relapsing MS (Type B recommendation). Also, mitoxantrone may have a beneficial effec...

Journal: :Current Opinion in Neurology 2015

Journal: :Multiple sclerosis 2017
Ali Manouchehrinia Omid Beiki Jan Hillert

BACKGROUND The course of multiple sclerosis (MS) has been studied in several cohorts; however, results have varied significantly. OBJECTIVE To describe the clinical course of MS in a nationwide cohort of patients. METHOD Data from the Swedish MS register (SMSreg) were used to estimate the median time to the sustained Expanded Disability Status Scale (EDSS) scores 3.0, 4.0 and 6.0, onset of ...

Journal: :Brain : a journal of neurology 2004
Catherine J Archibald Xingchang Wei James N Scott Carla J Wallace Yunyan Zhang Luanne M Metz J Ross Mitchell

The relationship between performance on information processing efficiency measures and MRI-derived lesion volume including global and regional T2 and T1 lesion volumes was investigated in 20 patients with relapsing-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS). Processing speed, as measured by the Sternberg Memory Scanning Test, was significantly correl...

Journal: :BMJ 1990
A J Thompson A G Kermode D G MacManus B E Kendall D P Kingsley I F Moseley W I McDonald

OBJECTIVE To compare the abnormalities shown by magnetic resonance imaging of the brain in three clinically distinct groups of patients with multiple sclerosis, and to correlate the extent of abnormality with the degree of clinical disability in the three groups. DESIGN All patients underwent magnetic resonance imaging and full neurological examination, and their disability was scored accordi...

Journal: :Brain : a journal of neurology 2014
Hugh Kearney Marios C Yiannakas Rebecca S Samson Claudia A M Wheeler-Kingshott Olga Ciccarelli David H Miller

Neuropathological studies in multiple sclerosis have suggested that meningeal inflammation in the brain may be linked to disease progression. Inflammation in the spinal cord meninges has been associated with axonal loss, a pathological substrate for disability. Quantitative magnetic resonance imaging facilitates the investigation of spinal cord microstructure by approximating histopathological ...

Journal: :PloS one 2016
Hanni S M Kiiski Sinéad Ní Riada Edmund C Lalor Nuno R Gonçalves Hugh Nolan Robert Whelan Róisín Lonergan Siobhán Kelly Marie Claire O'Brien Katie Kinsella Jessica Bramham Teresa Burke Seán Ó Donnchadha Michael Hutchinson Niall Tubridy Richard B Reilly

Conduction along the optic nerve is often slowed in multiple sclerosis (MS). This is typically assessed by measuring the latency of the P100 component of the Visual Evoked Potential (VEP) using electroencephalography. The Visual Evoked Spread Spectrum Analysis (VESPA) method, which involves modulating the contrast of a continuous visual stimulus over time, can produce a visually evoked response...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید